Solriamfetol
- Generic Name
- Solriamfetol
- Brand Names
- Sunosi
- Drug Type
- Small Molecule
- Chemical Formula
- C10H14N2O2
- CAS Number
- 178429-62-4
- Unique Ingredient Identifier
- 939U7C91AI
- Background
Solriamfetol marketed under the brand name Sunosi by Jazz Pharmaceuticals in the United States is a dopamine and norepinephrine reuptake inhibitor (DNRI) indicated in treating daytime sleepiness associated with narcolepsy or obstructive sleep apnea. Solriamfetol was given FDA approval in 2019.
- Indication
Solriamfetol is indicated for treatment of daytime sleepiness associated with obstructive sleep apnea and narcolepsy, but is not a treatment for the underlying airway obstruction in apnea patients.
- Associated Conditions
- Daytime Sleepiness
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath